The Aviva share price is on the rise. Should I buy now?

Rupert Hargreaves explains why he still likes the Aviva share price as the company’s growth strategy starts to pay off.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Aviva (LSE: AV) share price has surged over the past 12 months. Over the past year, shares in the financial services giant have added nearly 34%, excluding dividends. Over the same time frame, the FTSE 100 has returned just 13%, excluding dividends.

But even after this impressive performance, I still think the stock appears undervalued. 

Aviva share price performance 

During the past year, Aviva has been overhauling its business model. It’s agreed to sell eight non-core divisions, raising almost £8bn. These sales have undone much of the work completed by the former management, which wanted to take the group into new markets around the world. 

Under the leadership of its new CEO Amanda Blanc, the company is focusing on its core British, Irish and Canadian markets.

Blanc has also promised more deals and investment in the years ahead. A core part of Aviva’s strategy has been to move away from life insurance, which can be a tough business. 

Life insurance challenges 

Life insurance companies have some unique challenges. They have to manage assets and liabilities with precision to make sure policyholders can claim payouts over a multi-decade horizon. This is challenging because no one knows what will happen over the next few months, not to mention the next few decades.

Even a slight change in interest rates could have a considerable impact on life insurers’ profits and balance sheets. The company’s exposure to this challenging market may be one reason why investors have avoided the Aviva share price in the past. 

By comparison, non-life business tends to have a much shorter lead time. Car insurance is a great example. Customers pay a policy every year, and the insurer knows it may have to pay out in that year. If not, it can keep the cash. 

Less than a quarter of Aviva’s business is currently non-life, and management wants to increase its share of this more lucrative market. Some analysts have speculated that the company could use some of its newfound cash to buy up other UK insurers. That’s a possibility, but nothing has been announced yet. 

Strategy risks 

Of course, this strategy comes with risks. Aviva could be stepping out of its comfort zone, and this may lead to group losses. It could also end up alienating existing customers, which is something any corporation that relies on repeat business wants to avoid. If profits come under pressure for either of the above reasons, Aviva may have to re-think its growth plans. 

Still, I am encouraged by the firm’s recent progress, as well as the company’s hefty dividend yield. The Aviva share price currently supports a dividend yield of 6.9%, although this isn’t set in stone. If any of the risks outlined above materialise, management may have to reduce the payout. 

The stock is also selling at what I believe to be an attractive forward price-to-earnings (P/E) multiple of 7.2. Considering the firm’s potential, I reckon this severely undervalues the business. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »